Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2013

01-01-2013 | Epidemiology

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

Authors: Mariaelena Pierobon, Cara L. Frankenfeld

Published in: Breast Cancer Research and Treatment | Issue 1/2013

Login to get access

Abstract

Triple-negative breast cancer (TNBC) is a subtype of breast tumor with unique characteristics in terms of clinical−pathological presentation, prognosis, and response to therapy. Epidemiological investigations focusing on the identification of risk factors involved in the onset and progression of TNBCs have identified unique demographic, anthropometric, and reproductive characteristics involved in the etiopathogenesis of this subtype of breast tumors. This systematic review and meta-analysis evaluates the association between TNBCs and obesity and menopause status. Eligible articles were identified through three databases and secondary reference analysis. The search was conducted from the first record to February 2012. Eleven original articles meeting a priori established inclusion criteria were incorporated in the quantitative analysis. Case−case and case–control comparisons were performed. In addition, a case–case comparison was conducted before and after stratification according to menopausal status. Based on the level of between-study heterogeneity, pooled odds ratio (OR) and 95 % confidence interval were calculated using fixed or random models. The case−case comparison showed a significant association between TNBC and obesity (OR: 1.20; 95 % CI: 1.03−1.40). These results were confirmed by the case–control comparison (OR: 1.24; 95 % CI: 1.06−1.46). Once stratification based on menopausal status was applied to the case–case analysis, significant results were observed only in the pre-menopausal group (OR: 1.43; 95 % CI: 1.23−1.65). According to this analysis, obese women are at a greater risk of presenting with a TNBC than non-obese women, and menopause status may be a mitigating factor. If validated, these findings should be taken into consideration for the development of targeted preventive programs.
Literature
1.
go back to reference Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Patholology 41(1):40–47CrossRef Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Patholology 41(1):40–47CrossRef
2.
3.
go back to reference Perou C, Jeffrey S, Van de Rijn M et al (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci 96:9212–9217PubMedCrossRef Perou C, Jeffrey S, Van de Rijn M et al (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci 96:9212–9217PubMedCrossRef
4.
go back to reference Perou C, Sorlie T, Eisen M et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752PubMedCrossRef Perou C, Sorlie T, Eisen M et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752PubMedCrossRef
5.
go back to reference Sorlie T, Perou C, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci 98:10869–10874PubMedCrossRef Sorlie T, Perou C, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci 98:10869–10874PubMedCrossRef
6.
go back to reference Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938–1948PubMedCrossRef Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938–1948PubMedCrossRef
7.
go back to reference Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15 Pt 1):4429–4434PubMedCrossRef Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15 Pt 1):4429–4434PubMedCrossRef
8.
go back to reference De Ruijter TC, Veeck J, De Hoon JP et al (2011) Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137(2):183–192PubMedCrossRef De Ruijter TC, Veeck J, De Hoon JP et al (2011) Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137(2):183–192PubMedCrossRef
9.
go back to reference Irvin WJ Jr, Carey LA (2008) What is triple-negative breast cancer? Eur J Cancer 44(18):2799–2805PubMedCrossRef Irvin WJ Jr, Carey LA (2008) What is triple-negative breast cancer? Eur J Cancer 44(18):2799–2805PubMedCrossRef
10.
go back to reference Bauer KR, Brown M, Cress RD et al (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry. Cancer 109(9):1721–1728PubMedCrossRef Bauer KR, Brown M, Cress RD et al (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry. Cancer 109(9):1721–1728PubMedCrossRef
11.
go back to reference Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt) 18(6):883–893CrossRef Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt) 18(6):883–893CrossRef
12.
go back to reference Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247–2258PubMedCrossRef Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247–2258PubMedCrossRef
13.
go back to reference Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1):33–38PubMedCrossRef Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1):33–38PubMedCrossRef
14.
go back to reference Van den Brandt PA, Spiegelman D, Yaun SS et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527PubMedCrossRef Van den Brandt PA, Spiegelman D, Yaun SS et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527PubMedCrossRef
15.
go back to reference Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111(5):762–771PubMedCrossRef Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111(5):762–771PubMedCrossRef
16.
go back to reference Rose DP, Vona-Davis L (2009) Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 9(8):1091–1101PubMedCrossRef Rose DP, Vona-Davis L (2009) Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 9(8):1091–1101PubMedCrossRef
17.
go back to reference Phipps AI, Malone KE, Porter PL et al (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(8):2078–2086PubMedCrossRef Phipps AI, Malone KE, Porter PL et al (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(8):2078–2086PubMedCrossRef
18.
go back to reference Aronne LJ (2002) Classification of obesity and assessment of obesity-related health risks. Obes Res 10(Suppl 2):105S–115SPubMedCrossRef Aronne LJ (2002) Classification of obesity and assessment of obesity-related health risks. Obes Res 10(Suppl 2):105S–115SPubMedCrossRef
19.
go back to reference Guyatt GH, Oxman AD, Vist G et al (2011) GRADE guidelines: 4. rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 64(4):407–415PubMedCrossRef Guyatt GH, Oxman AD, Vist G et al (2011) GRADE guidelines: 4. rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 64(4):407–415PubMedCrossRef
20.
go back to reference Sutton AJ, Abrams KR, Jones DR et al (2000) Methods for meta-analysis in medical research. Wiley series in probability and statistics-applied probability and statistics section. Wiley, Hoboken Sutton AJ, Abrams KR, Jones DR et al (2000) Methods for meta-analysis in medical research. Wiley series in probability and statistics-applied probability and statistics section. Wiley, Hoboken
21.
go back to reference Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139PubMedCrossRef Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139PubMedCrossRef
22.
go back to reference Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11(3):R31PubMedCrossRef Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11(3):R31PubMedCrossRef
23.
go back to reference Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20(7):1071–1082PubMedCrossRef Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20(7):1071–1082PubMedCrossRef
24.
go back to reference Gaudet MM, Press MF, Haile RW et al (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130(2):587–597PubMedCrossRef Gaudet MM, Press MF, Haile RW et al (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130(2):587–597PubMedCrossRef
25.
go back to reference Phipps AI, Chlebowski RT, Prentice R et al (2011) Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 20(3):454–463PubMedCrossRef Phipps AI, Chlebowski RT, Prentice R et al (2011) Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 20(3):454–463PubMedCrossRef
26.
go back to reference Suzuki R, Orsini N, Saji S et al (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis. Int J Cancer 124(3):698–712PubMedCrossRef Suzuki R, Orsini N, Saji S et al (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis. Int J Cancer 124(3):698–712PubMedCrossRef
27.
go back to reference Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14(2):189–206PubMedCrossRef Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14(2):189–206PubMedCrossRef
28.
go back to reference Schäffler A, Schölmerich J, Buechler C (2007) Mechanisms of disease: adipokines and breast cancer-endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 3(4):345–354PubMedCrossRef Schäffler A, Schölmerich J, Buechler C (2007) Mechanisms of disease: adipokines and breast cancer-endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 3(4):345–354PubMedCrossRef
29.
go back to reference Bulun SE, Chen D, Moy I et al (2012) Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab 23(2):83–89PubMedCrossRef Bulun SE, Chen D, Moy I et al (2012) Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab 23(2):83–89PubMedCrossRef
30.
31.
go back to reference Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279–292PubMedCrossRef Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279–292PubMedCrossRef
32.
go back to reference Federico A, Morgillo F, Tuccillo C et al (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121(11):2381–2386PubMedCrossRef Federico A, Morgillo F, Tuccillo C et al (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121(11):2381–2386PubMedCrossRef
33.
go back to reference Daling JR, Malone KE, Doody DR et al (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92(4):720–729PubMedCrossRef Daling JR, Malone KE, Doody DR et al (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92(4):720–729PubMedCrossRef
34.
go back to reference Goodwin PJ, Boyd NF (1990) Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 16(3):205–214PubMedCrossRef Goodwin PJ, Boyd NF (1990) Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 16(3):205–214PubMedCrossRef
35.
go back to reference Loi S, Milne RL, Friedlander ML et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14(7):1686–1691PubMedCrossRef Loi S, Milne RL, Friedlander ML et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14(7):1686–1691PubMedCrossRef
36.
go back to reference Gillespie EF, Sorbero ME, Hanauer DA et al (2010) Obesity and angiolymphatic invasion in primary breast cancer. Ann Surg Oncol 17(3):752–759PubMedCrossRef Gillespie EF, Sorbero ME, Hanauer DA et al (2010) Obesity and angiolymphatic invasion in primary breast cancer. Ann Surg Oncol 17(3):752–759PubMedCrossRef
37.
go back to reference Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012PubMedCrossRef Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012PubMedCrossRef
38.
go back to reference Vona-Davis L, Rose DP, Hazard H et al (2008) Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev 17(12):3319–3324PubMedCrossRef Vona-Davis L, Rose DP, Hazard H et al (2008) Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev 17(12):3319–3324PubMedCrossRef
39.
go back to reference Dolle JM, Daling JR, White E et al (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 18(4):1157–1166PubMedCrossRef Dolle JM, Daling JR, White E et al (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 18(4):1157–1166PubMedCrossRef
40.
go back to reference Stead LA, Lash TL, Sobieraj JE et al (2009) Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res 11(2):R18PubMedCrossRef Stead LA, Lash TL, Sobieraj JE et al (2009) Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res 11(2):R18PubMedCrossRef
41.
go back to reference Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. Natl Cancer Inst 103(3):250–263CrossRef Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. Natl Cancer Inst 103(3):250–263CrossRef
42.
go back to reference Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D et al (2011) Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 117(16):3658–3669PubMedCrossRef Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D et al (2011) Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 117(16):3658–3669PubMedCrossRef
Metadata
Title
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis
Authors
Mariaelena Pierobon
Cara L. Frankenfeld
Publication date
01-01-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2339-3

Other articles of this Issue 1/2013

Breast Cancer Research and Treatment 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine